Allen Patricia L — SEC Form 4 filings
SEC reporting owner CIK 1348587. 6 Form 4 filings on record with FilingPulse; latest filed 2026-06-17.
Transaction summary — filings shown
Covers all 6 filings on record, filed 2024-01-18 to 2026-06-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 4 legs across 1 filing — 19,860 shares, $499,746 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: purchase of 5,700 shares @ $24.34 ($138,738) in Zenas BioPharma, Inc., filed 2026-02-13.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Zenas BioPharma, Inc. (ZBIO) | Director | 4 | 4 legs · 19,860 sh · $499,746 | — | 3 |
| Deciphera Pharmaceuticals, Inc. | Director | 2 | — | — | 9 |
Form 4 filings — Allen Patricia L
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-17 | 4 | Zenas BioPharma, Inc. (ZBIO) | Grant/award (A): 18,500 (derivative) @ $0 | EDGAR |
| 2026-02-13 | 4 | Zenas BioPharma, Inc. (ZBIO) | Purchase (P): 5,000 @ $23.77 · Purchase (P): 5,700 @ $24.34 · Purchase (P): 5,000 @ $26.50 · Purchase (P): 4,160 @ $26.36 | EDGAR |
| 2025-06-12 | 4 | Zenas BioPharma, Inc. (ZBIO) | Grant/award (A): 18,500 (derivative) @ $0 | EDGAR |
| 2024-09-16 | 4 | Zenas BioPharma, Inc. (ZBIO) | Grant/award (A): 18,500 (derivative) @ $0 | EDGAR |
| 2024-06-11 | 4 | Deciphera Pharmaceuticals, Inc. | Disposition to issuer (D): 10,233 (derivative) · Disposition to issuer (D): 7,181 (derivative) · Disposition to issuer (D): 12,000 (derivative) · Disposition to issuer (D): 9,570 (derivative) · Disposition to issuer (D): 18,500 (derivative) · Disposition to issuer (D): 3,269 (derivative) · +2 more | EDGAR |
| 2024-01-18 | 4 | Deciphera Pharmaceuticals, Inc. (DCPH) | Grant/award (A): 4,727 (derivative) @ $10.58 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1348587 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →